Abacavir And Lamivudine - ABEC-L Tablets

Q1: What is Abacavir + Lamivudine (ABEC-L) used for?

This dual NRTI backbone combination is used as the foundation of combination HIV-1 therapy. When combined with an INSTI, NNRTI, or boosted PI as a third agent, it provides potent, durable viral suppression.

Q2: How do Abacavir and Lamivudine work together?

Both are NRTIs that inhibit HIV reverse transcriptase, but through slightly different mechanisms: Abacavir (as carbovir triphosphate) and Lamivudine (as lamivudine triphosphate) both terminate viral DNA synthesis, with synergistic anti-HIV activity that reduces the risk of resistance compared to either alone.

Q3: What is the HLA-B*5701 test and is it required?

HLA-B*5701 testing is mandatory before starting Abacavir. Patients positive for this allele have a 50–60% risk of Abacavir hypersensitivity syndrome. If positive, the ABEC-L combination cannot be used — alternative NRTIs such as TDF/FTC must be chosen.

Q4: What is the dosing for ABEC-L tablets?

The fixed-dose combination is taken once or twice daily as prescribed. Common regimens include Abacavir 300mg + Lamivudine 150mg twice daily, or as a once-daily 600/300mg combination. Always take at consistent times.

Q5: What are the most common side effects?

Nausea, diarrhea, headache, fatigue, and insomnia are most common, particularly in the first few weeks. Lamivudine is generally well-tolerated; Abacavir HSR symptoms (fever, rash, GI disturbance) must be distinguished from normal side effects.

Q6: What is the Abacavir hypersensitivity reaction?

HSR is a multi-system reaction affecting 2–8% of HLA-B*5701 non-screened patients, causing fever, rash, fatigue, GI symptoms, and respiratory symptoms within the first 6 weeks. Stop Abacavir IMMEDIATELY if suspected and never rechallenge — fatal hypotension can occur on reexposure.

Q7: Can Lamivudine be used for hepatitis B as well?

Yes. Lamivudine is active against both HIV and hepatitis B virus (HBV). If a patient has HIV/HBV co-infection, stopping Lamivudine can cause HBV flares. Never stop Lamivudine in HIV/HBV co-infected patients without specialist guidance.

Q8: What serious side effects require emergency care?

Seek immediate care for: hypersensitivity reaction symptoms (fever + rash), lactic acidosis (muscle pain, weakness, breathing difficulty), or hepatitis flare in HBV co-infected patients if Lamivudine is stopped.

Q9: Can ABEC-L be used during pregnancy?

Abacavir + Lamivudine is used in pregnancy following HLA testing. Lamivudine is well-studied in pregnancy. Discuss the full antiretroviral regimen with your HIV specialist and obstetric team.

Q10: What monitoring is required during treatment?

CD4 count and viral load at baseline and every 3–6 months. Liver function tests (especially if HBV co-infected). Watch for HSR symptoms in the first 6 weeks. HLA-B*5701 must be confirmed before initiating.

Q11: How should ABEC-L be stored?

Store at room temperature away from light and moisture. Keep in original packaging and out of reach of children.

Q12: Do I need a prescription for ABEC-L?

Yes. This dual NRTI combination requires specialist HIV prescribing, HLA-B*5701 testing, and ongoing monitoring of viral load and CD4 count.